API Suppliers
US DMFs Filed
CEP/COS Certifications
0
JDMFs Filed
0
Other Certificates
Other Suppliers
USA (Orange Book)
Europe
Canada
Australia
South Africa
Uploaded Dossiers
0
U.S. Medicaid
Annual Reports
17
PharmaCompass offers a list of Lisdexamfetamine Dimesylate API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Lisdexamfetamine Dimesylate manufacturer or Lisdexamfetamine Dimesylate supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Lisdexamfetamine Dimesylate manufacturer or Lisdexamfetamine Dimesylate supplier.
PharmaCompass also assists you with knowing the Lisdexamfetamine Dimesylate API Price utilized in the formulation of products. Lisdexamfetamine Dimesylate API Price is not always fixed or binding as the Lisdexamfetamine Dimesylate Price is obtained through a variety of data sources. The Lisdexamfetamine Dimesylate Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Lisdexamfetamine Dimesylate manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Lisdexamfetamine Dimesylate, including repackagers and relabelers. The FDA regulates Lisdexamfetamine Dimesylate manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Lisdexamfetamine Dimesylate API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Lisdexamfetamine Dimesylate manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Lisdexamfetamine Dimesylate supplier is an individual or a company that provides Lisdexamfetamine Dimesylate active pharmaceutical ingredient (API) or Lisdexamfetamine Dimesylate finished formulations upon request. The Lisdexamfetamine Dimesylate suppliers may include Lisdexamfetamine Dimesylate API manufacturers, exporters, distributors and traders.
click here to find a list of Lisdexamfetamine Dimesylate suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Lisdexamfetamine Dimesylate DMF (Drug Master File) is a document detailing the whole manufacturing process of Lisdexamfetamine Dimesylate active pharmaceutical ingredient (API) in detail. Different forms of Lisdexamfetamine Dimesylate DMFs exist exist since differing nations have different regulations, such as Lisdexamfetamine Dimesylate USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Lisdexamfetamine Dimesylate DMF submitted to regulatory agencies in the US is known as a USDMF. Lisdexamfetamine Dimesylate USDMF includes data on Lisdexamfetamine Dimesylate's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Lisdexamfetamine Dimesylate USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Lisdexamfetamine Dimesylate suppliers with USDMF on PharmaCompass.
A Lisdexamfetamine Dimesylate written confirmation (Lisdexamfetamine Dimesylate WC) is an official document issued by a regulatory agency to a Lisdexamfetamine Dimesylate manufacturer, verifying that the manufacturing facility of a Lisdexamfetamine Dimesylate active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Lisdexamfetamine Dimesylate APIs or Lisdexamfetamine Dimesylate finished pharmaceutical products to another nation, regulatory agencies frequently require a Lisdexamfetamine Dimesylate WC (written confirmation) as part of the regulatory process.
click here to find a list of Lisdexamfetamine Dimesylate suppliers with Written Confirmation (WC) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Lisdexamfetamine Dimesylate as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Lisdexamfetamine Dimesylate API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Lisdexamfetamine Dimesylate as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Lisdexamfetamine Dimesylate and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Lisdexamfetamine Dimesylate NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Lisdexamfetamine Dimesylate suppliers with NDC on PharmaCompass.
Lisdexamfetamine Dimesylate Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Lisdexamfetamine Dimesylate GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Lisdexamfetamine Dimesylate GMP manufacturer or Lisdexamfetamine Dimesylate GMP API supplier for your needs.
A Lisdexamfetamine Dimesylate CoA (Certificate of Analysis) is a formal document that attests to Lisdexamfetamine Dimesylate's compliance with Lisdexamfetamine Dimesylate specifications and serves as a tool for batch-level quality control.
Lisdexamfetamine Dimesylate CoA mostly includes findings from lab analyses of a specific batch. For each Lisdexamfetamine Dimesylate CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Lisdexamfetamine Dimesylate may be tested according to a variety of international standards, such as European Pharmacopoeia (Lisdexamfetamine Dimesylate EP), Lisdexamfetamine Dimesylate JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Lisdexamfetamine Dimesylate USP).